☰

Ziva D. Cooper, Ph.D. - Publications

Affiliations: 
2001-2007 Biopsychology University of Michigan, Ann Arbor, Ann Arbor, MI 
 2007- Psychiatry Columbia University College of Physicians and Surgeons, New York, NY, United States 
 2007- Psychiatry New York State Psychiatric Institute, New York, NY, United States 
Area:
behavioral pharmacology, opioids, cannabinoids, cannabis, pain, substance use
Tree Info Grants Similar researchers PubMed Report error

54/97 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Murray CH, Haney M, Foltin RW, Manubay J, Bedi G, Cooper ZD. Smoked cannabis reduces peak cocaine plasma levels and subjective effects in a controlled drug administration study of polysubstance use in men. Drug and Alcohol Dependence. 243: 109757. PMID 36608482 DOI: 10.1016/j.drugalcdep.2022.109757  0.329
2021 Lake S, Kerr T, Buxton J, Walsh Z, Cooper ZD, Socías ME, Fairbairn N, Hayashi K, Milloy MJ. The Cannabis-Dependent Relationship Between Methadone Treatment Dose and Illicit Opioid Use in a Community-Based Cohort of People Who Use Drugs. Cannabis and Cannabinoid Research. PMID 34813374 DOI: 10.1089/can.2021.0080  0.321
2019 Lake S, Walsh Z, Kerr T, Cooper ZD, Buxton J, Wood E, Ware MA, Milloy MJ. Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis. Plos Medicine. 16: e1002967. PMID 31743343 DOI: 10.1371/Journal.Pmed.1002967  0.373
2019 Cooper ZD, Abrams D. Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies. The American Journal of Drug and Alcohol Abuse. 1-16. PMID 31687845 DOI: 10.1080/00952990.2019.1669628  0.364
2019 Chao T, Haney M, Cooper ZD, Vadhan NP, Van Dam NT, Van Snellenberg J, Bedi G. Cognitive function in aging cocaine smokers. Journal of Psychopharmacology (Oxford, England). 269881119849812. PMID 31169441 DOI: 10.1177/0269881119849812  0.377
2018 Herrmann ES, Cooper ZD, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin RW, Haney M. Varenicline and nabilone in tobacco and cannabis co-users: effects on tobacco abstinence, withdrawal and a laboratory model of cannabis relapse. Addiction Biology. PMID 30378231 DOI: 10.1111/Adb.12664  0.343
2018 Bedi G, Hao X, Van Dam NT, Cooper ZD, Rubin E, Vadhan NP, Marino L, Haney M. Social motivational processing and interpersonal function in aging cocaine smokers. Addiction Biology. PMID 30328665 DOI: 10.1111/Adb.12669  0.395
2018 Haney M, Cooper ZD, Bedi G, Herrmann E, Comer SD, Reed SC, Foltin RW, Levin FR. Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers. Addiction Biology. PMID 29659126 DOI: 10.1111/Adb.12621  0.381
2018 Cooper ZD, Bedi G, Ramesh D, Balter R, Comer SD, Haney M. Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 29463913 DOI: 10.1038/S41386-018-0011-2  0.446
2018 Bedi G, Hao X, Van Dam N, Cooper Z, Vadhan N, Haney M. F259. Social Motivational Processing and Interpersonal Function in Aging Cocaine Smokers Biological Psychiatry. 83: S339-S340. DOI: 10.1016/J.Biopsych.2018.02.873  0.364
2017 Cooper ZD, Craft RM. Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28811670 DOI: 10.1038/Npp.2017.140  0.314
2017 Cooper ZD, Johnson KW, Vosburg SK, Sullivan MA, Manubay J, Martinez D, Jones JD, Saccone PA, Comer SD. Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers. Drug and Alcohol Dependence. 178: 340-347. PMID 28688296 DOI: 10.1016/J.Drugalcdep.2017.04.029  0.407
2017 Herrmann ES, Cooper Z, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin R, Haney M. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and relapse among non-treatment-seeking cannabis users Drug and Alcohol Dependence. 171: e88. DOI: 10.1016/J.Drugalcdep.2016.08.247  0.315
2017 Cooper ZD, Comer SD, Haney M. Opioid modulation of cannabis-induced analgesia and subjective effects in cannabis smokers Drug and Alcohol Dependence. 171: e44-e45. DOI: 10.1016/J.Drugalcdep.2016.08.135  0.392
2016 Cooper ZD, Haney M. Sex-dependent effects of cannabis-induced analgesia. Drug and Alcohol Dependence. PMID 27522535 DOI: 10.1016/J.Drugalcdep.2016.08.001  0.338
2016 Herrmann ES, Cooper ZD, Bedi G, Ramesh D, Reed SC, Comer SD, Foltin RW, Haney M. Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users. Psychopharmacology. PMID 27085870 DOI: 10.1007/S00213-016-4298-6  0.314
2016 Cooper ZD. Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal. Current Psychiatry Reports. 18: 52. PMID 27074934 DOI: 10.1007/S11920-016-0694-1  0.37
2015 Haney M, Malcolm RJ, Babalonis S, Nuzzo PA, Cooper ZD, Bedi G, Gray KM, McRae-Clark A, Lofwall MR, Sparenborg S, Walsh SL. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26708108 DOI: 10.1038/Npp.2015.367  0.413
2015 Cooper ZD, Johnson KW, Pavlicova M, Glass A, Vosburg SK, Sullivan MA, Manubay JM, Martinez DM, Jones JD, Saccone PA, Comer SD. The effects of ibudilast, a glial activation inhibitor, on opioid withdrawal symptoms in opioid-dependent volunteers. Addiction Biology. PMID 25975386 DOI: 10.1111/Adb.12261  0.419
2015 Haney M, Ramesh D, Glass A, Pavlicova M, Bedi G, Cooper ZD. Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 25881117 DOI: 10.1038/Npp.2015.108  0.437
2015 Bedi G, Cooper ZD, Van Dam N, Haney M. Social processing in aging cocaine smokers Drug and Alcohol Dependence. 156: e17-e18. DOI: 10.1016/J.Drugalcdep.2015.07.966  0.385
2015 Cooper ZD, Haney M. Synthetic cannabinoid use in cannabis smokers Drug and Alcohol Dependence. 146: e250. DOI: 10.1016/J.Drugalcdep.2014.09.146  0.4
2014 Balter RE, Cooper ZD, Haney M. Novel Pharmacologic Approaches to Treating Cannabis Use Disorder. Current Addiction Reports. 1: 137-143. PMID 24955304 DOI: 10.1007/S40429-014-0011-1  0.327
2014 Cooper ZD, Haney M. Investigation of sex-dependent effects of cannabis in daily cannabis smokers. Drug and Alcohol Dependence. 136: 85-91. PMID 24440051 DOI: 10.1016/J.Drugalcdep.2013.12.013  0.331
2014 Sullivan M, Manubay J, Vosburg SK, Jones J, Cooper ZD, Fogel J, Davidson J, Comer SD. Buprenorphine/naloxone for the treatment of prescription opioid abuse and chronic pain Drug and Alcohol Dependence. 140: e220. DOI: 10.1016/J.Drugalcdep.2014.02.610  0.389
2014 Ramesh D, Haney M, Cooper ZD. Dose-dependent physiological and subjective effects of marijuana in daily marijuana smokers Drug and Alcohol Dependence. 140: e181-e182. DOI: 10.1016/J.Drugalcdep.2014.02.509  0.361
2014 Manubay JM, Davidson J, Vosburg S, Jones JD, Cooper ZD, Fogel J, Comer SD, Sullivan M. Sex differences among opioid-abusing chronic pain patients in a clinical trial Drug and Alcohol Dependence. 140: e133. DOI: 10.1016/J.Drugalcdep.2014.02.378  0.334
2013 Ramesh D, Haney M, Cooper ZD. Marijuana's dose-dependent effects in daily marijuana smokers. Experimental and Clinical Psychopharmacology. 21: 287-93. PMID 23937597 DOI: 10.1037/A0033661  0.371
2013 Comer SD, Metz VE, Cooper ZD, Kowalczyk WJ, Jones JD, Sullivan MA, Manubay JM, Vosburg SK, Smith ME, Peyser D, Saccone PA. Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts. Behavioural Pharmacology. 24: 504-16. PMID 23839029 DOI: 10.1097/Fbp.0B013E328363D1C4  0.382
2013 Comer SD, Mogali S, Saccone PA, Askalsky P, Martinez D, Walker EA, Jones JD, Vosburg SK, Cooper ZD, Roux P, Sullivan MA, Manubay JM, Rubin E, Pines A, Berkower EL, et al. Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2427-38. PMID 23736314 DOI: 10.1038/Npp.2013.143  0.642
2013 Roux P, Sullivan MA, Cohen J, Fugon L, Jones JD, Vosburg SK, Cooper ZD, Manubay JM, Mogali S, Comer SD. Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone. Pain. 154: 1442-8. PMID 23707283 DOI: 10.1016/J.Pain.2013.05.004  0.408
2013 Cooper ZD, Comer SD, Haney M. Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1984-92. PMID 23609132 DOI: 10.1038/Npp.2013.97  0.335
2013 Haney M, Cooper ZD, Bedi G, Vosburg SK, Comer SD, Foltin RW. Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 1557-65. PMID 23443718 DOI: 10.1038/Npp.2013.54  0.403
2013 Cooper ZD, Foltin RW, Evans SM. Effects of menstrual cycle phase on cocaine self-administration in rhesus macaques. Hormones and Behavior. 63: 105-13. PMID 23098805 DOI: 10.1016/J.Yhbeh.2012.10.008  0.44
2013 Cooper ZD, Foltin RW, Hart CL, Vosburg SK, Comer SD, Haney M. A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers. Addiction Biology. 18: 993-1002. PMID 22741619 DOI: 10.1111/J.1369-1600.2012.00461.X  0.384
2013 Bedi G, Cooper ZD, Haney M. Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers. Addiction Biology. 18: 872-81. PMID 22260337 DOI: 10.1111/J.1369-1600.2011.00427.X  0.404
2012 Cooper ZD, Sullivan MA, Vosburg SK, Manubay JM, Haney M, Foltin RW, Evans SM, Kowalczyk WJ, Saccone PA, Comer SD. Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteers. Behavioural Pharmacology. 23: 271-9. PMID 22495183 DOI: 10.1097/Fbp.0B013E3283536D6F  0.41
2012 Cooper ZD, Jones JD, Comer SD. Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances. Expert Opinion On Investigational Drugs. 21: 169-78. PMID 22233449 DOI: 10.1517/13543784.2012.651123  0.35
2012 Roux P, Tindall C, Fugon L, Murray J, Vosburg SK, Saccone P, Sullivan MA, Manubay JM, Cooper ZD, Jones JD, Foltin RW, Comer SD. Impact of in-patient research participation on subsequent heroin use patterns: implications for ethics and public health. Addiction (Abingdon, England). 107: 642-9. PMID 21939462 DOI: 10.1111/J.1360-0443.2011.03664.X  0.356
2011 Gooch CM, Rakitin BC, Cooper ZD, Comer SD, Balsam PD. Oxycodone lengthens reproductions of suprasecond time intervals in human research volunteers. Behavioural Pharmacology. 22: 354-61. PMID 21750426 DOI: 10.1097/Fbp.0B013E328348D8B8  0.384
2010 Cooper ZD, Shi YG, Woods JH. Reinforcer-dependent enhancement of operant responding in opioid-withdrawn rats. Psychopharmacology. 212: 369-78. PMID 20686752 DOI: 10.1007/S00213-010-1966-9  0.586
2010 Haney M, Hart CL, Vosburg SK, Comer SD, Reed SC, Cooper ZD, Foltin RW. Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse. Psychopharmacology. 211: 233-44. PMID 20521030 DOI: 10.1007/S00213-010-1888-6  0.392
2010 Cooper ZD, Haney M. Opioid antagonism enhances marijuana's effects in heavy marijuana smokers. Psychopharmacology. 211: 141-8. PMID 20490465 DOI: 10.1007/S00213-010-1875-Y  0.429
2010 Comer SD, Sullivan MA, Vosburg SK, Manubay J, Amass L, Cooper ZD, Saccone P, Kleber HD. Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers. Addiction (Abingdon, England). 105: 709-18. PMID 20403021 DOI: 10.1111/J.1360-0443.2009.02843.X  0.443
2010 Comer SD, Cooper ZD, Kowalczyk WJ, Sullivan MA, Evans SM, Bisaga AM, Vosburg SK. Evaluation of potential sex differences in the subjective and analgesic effects of morphine in normal, healthy volunteers. Psychopharmacology. 208: 45-55. PMID 19859698 DOI: 10.1007/S00213-009-1703-4  0.381
2010 Wood SK, Narasimhan D, Cooper Z, Sunahara RK, Woods JH. Prevention and reversal by cocaine esterase of cocaine-induced cardiovascular effects in rats. Drug and Alcohol Dependence. 106: 219-29. PMID 19800183 DOI: 10.1016/J.Drugalcdep.2009.09.001  0.686
2010 Jutkiewicz EM, Baladi MG, Cooper ZD, Woods JH. In reply Annals of Emergency Medicine. 55: 485-486. DOI: 10.1016/j.annemergmed.2009.11.028  0.567
2009 Cooper ZD, Haney M. Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence. International Review of Psychiatry (Abingdon, England). 21: 104-12. PMID 19367504 DOI: 10.1080/09540260902782752  0.381
2009 Jutkiewicz EM, Baladi MG, Cooper ZD, Narasimhan D, Sunahara RK, Woods JH. A bacterial cocaine esterase protects against cocaine-induced epileptogenic activity and lethality. Annals of Emergency Medicine. 54: 409-20. PMID 19013687 DOI: 10.1016/J.Annemergmed.2008.09.023  0.691
2008 Cooper ZD, Truong YN, Shi YG, Woods JH. Morphine deprivation increases self-administration of the fast- and short-acting mu-opioid receptor agonist remifentanil in the rat. The Journal of Pharmacology and Experimental Therapeutics. 326: 920-9. PMID 18515643 DOI: 10.1124/Jpet.108.139196  0.568
2008 Cooper ZD, Haney M. Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor. Addiction Biology. 13: 188-95. PMID 18279497 DOI: 10.1111/J.1369-1600.2007.00095.X  0.362
2007 Ko MC, Bowen LD, Narasimhan D, Berlin AA, Lukacs NW, Sunahara RK, Cooper ZD, Woods JH. Cocaine esterase: interactions with cocaine and immune responses in mice. The Journal of Pharmacology and Experimental Therapeutics. 320: 926-33. PMID 17114567 DOI: 10.1124/Jpet.106.114223  0.591
2006 Cooper ZD, Narasimhan D, Sunahara RK, Mierzejewski P, Jutkiewicz EM, Larsen NA, Wilson IA, Landry DW, Woods JH. Rapid and robust protection against cocaine-induced lethality in rats by the bacterial cocaine esterase. Molecular Pharmacology. 70: 1885-91. PMID 16968810 DOI: 10.1124/Mol.106.025999  0.697
2001 Houshyar H, Cooper ZD, Woods JH. Paradoxical effects of chronic morphine treatment on the temperature and pituitary-adrenal responses to acute restraint stress: a chronic stress paradigm. Journal of Neuroendocrinology. 13: 862-74. PMID 11679055 DOI: 10.1046/J.1365-2826.2001.00713.X  0.69
Low-probability matches (unlikely to be authored by this person)
2013 Haney M, Bedi G, Cooper ZD, Glass A, Vosburg SK, Comer SD, Foltin RW. Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status. Biological Psychiatry. 73: 242-8. PMID 22939992 DOI: 10.1016/J.Biopsych.2012.07.028  0.298
2009 Cooper ZD, Haney M. Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts. Drug and Alcohol Dependence. 103: 107-13. PMID 19443132 DOI: 10.1016/J.Drugalcdep.2009.01.023  0.297
2019 Adinoff B, Cooper ZD. Cannabis legalization: progress in harm reduction approaches for substance use and misuse. The American Journal of Drug and Alcohol Abuse. 45: 707-712. PMID 31755837 DOI: 10.1080/00952990.2019.1680683  0.296
2017 Cooper ZD, Poklis JL, Liu F. Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073. Neuropharmacology. PMID 29146503 DOI: 10.1016/J.Neuropharm.2017.11.020  0.287
2021 Arout CA, Cooper ZD, Reed SC, Foltin RW, Comer SD, Levin FR, Haney M. 5HT-2C agonist lorcaserin decreases cannabis self-administration in daily cannabis smokers. Addiction Biology. e12993. PMID 33389797 DOI: 10.1111/adb.12993  0.282
2020 Venegas A, Meredith LR, Green R, Cooper ZD, Ray LA. Sex-dependent effects of alcohol administration on the urge to use cannabis. Experimental and Clinical Psychopharmacology. PMID 32658530 DOI: 10.1037/Pha0000409  0.271
2022 Haney M, Bedi G, Cooper ZD, Herrmann ES, Reed SC, Foltin RW, Kingsley PJ, Marnett LJ, Patel S. Impact of cyclooxygenase-2 inhibition on cannabis withdrawal and circulating endocannabinoids in daily cannabis smokers. Addiction Biology. 27: e13183. PMID 35754107 DOI: 10.1111/adb.13183  0.27
2021 Arout CA, Haney M, Herrmann ES, Bedi G, Cooper ZD. The dose-dependent analgesic effects, abuse liability, safety and tolerability of oral cannabidiol in healthy humans. British Journal of Clinical Pharmacology. PMID 34223660 DOI: 10.1111/bcp.14973  0.27
2022 Lake S, Buxton J, Walsh Z, Cooper ZD, Socías ME, Fairbairn N, Hayashi K, Milloy MJ. Methadone Dose, Cannabis Use, and Treatment Retention: Findings From a Community-based Sample of People Who Use Unregulated Drugs. Journal of Addiction Medicine. PMID 35914028 DOI: 10.1097/ADM.0000000000001032  0.247
2019 Cooper ZD, Adinoff B. Necessity of addressing motivations for cannabis use to guide research. The American Journal of Drug and Alcohol Abuse. 45: 547-550. PMID 31755836 DOI: 10.1080/00952990.2019.1680991  0.246
2020 Sihota A, Smith BK, Ahmed SA, Bell A, Blain A, Clarke H, Cooper ZD, Cyr C, Daeninck P, Deshpande A, Ethans K, Flusk D, Le Foll B, Milloy MJ, Moulin DE, et al. Consensus-Based Recommendations for Titrating Cannabinoids and Tapering Opioids for Chronic Pain Control. International Journal of Clinical Practice. e13871. PMID 33249713 DOI: 10.1111/ijcp.13871  0.243
2021 Cooper ZD, Evans SM, Foltin RW. Self-administration of inhaled delta-9-tetrahydrocannabinol and synthetic cannabinoids in non-human primates. Experimental and Clinical Psychopharmacology. 29: 137-146. PMID 34043398 DOI: 10.1037/pha0000457  0.24
2023 Lake S, Haney M, Cooper ZD. Sex differences in the subjective and reinforcing effects of smoked cannabis. Addiction Biology. 28: e13301. PMID 37369126 DOI: 10.1111/adb.13301  0.24
2018 Piomelli D, Weiss S, Boyd G, Pacula RL, Cooper Z. Cannabis and the Opioid Crisis. Cannabis and Cannabinoid Research. 3: 108-116. PMID 29789812 DOI: 10.1089/can.2018.29011.rtl  0.234
2023 Haney M, Vallée M, Fabre S, Collins Reed S, Zanese M, Campistron G, Arout CA, Foltin RW, Cooper ZD, Kearney-Ramos T, Metna M, Justinova Z, Schindler C, Hebert-Chatelain E, Bellocchio L, et al. Signaling-specific inhibition of the CB receptor for cannabis use disorder: phase 1 and phase 2a randomized trials. Nature Medicine. PMID 37291212 DOI: 10.1038/s41591-023-02381-w  0.225
2022 Lake S, Assaf RD, Gorbach PM, Cooper ZD. Changes in secondary substance use after the onset of the COVID-19 pandemic among people who use cannabis: Findings from a web-based sample of adults in the United States. Experimental and Clinical Psychopharmacology. PMID 35467920 DOI: 10.1037/pha0000572  0.224
2020 Venegas A, Meredith LR, Cooper ZD, Towns B, Ray LA. Inclusion of Cannabis Users in Alcohol Research Samples: Screening In, Screening Out, and Implications. Alcohol and Alcoholism (Oxford, Oxfordshire). PMID 32328657 DOI: 10.1093/Alcalc/Agaa023  0.224
2023 Assaf RD, Javanbakht M, Gorbach PM, Arah OA, Shoptaw SJ, Cooper ZD. Puff, Puff, Don't Pass: harm reduction for cannabis use during a viral respiratory pandemic. Harm Reduction Journal. 20: 23. PMID 36829150 DOI: 10.1186/s12954-023-00751-8  0.209
2022 Middlekauff HR, Cooper ZD, Strauss SB. Drugs of Misuse: Focus on Vascular Dysfunction. The Canadian Journal of Cardiology. PMID 35462024 DOI: 10.1016/j.cjca.2022.04.011  0.197
2023 Pabon E, Cooper ZD. Controlled human drug administration studies are necessary to define the THC-sparing effects of CBD and other cannabis constituents. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 36725865 DOI: 10.1038/s41386-023-01538-y  0.177
2022 First OK, MacGibbon KW, Cahill CM, Cooper ZD, Gelberg L, Cortessis VK, Mullin PM, Fejzo MS. Patterns of Use and Self-reported Effectiveness of Cannabis for Hyperemesis Gravidarum. Geburtshilfe Und Frauenheilkunde. 82: 517-527. PMID 35528189 DOI: 10.1055/a-1749-5391  0.169
2023 Farkas DJ, Cooper ZD, Heydari LN, Hughes AC, Rawls SM, Ward SJ. Kratom Alkaloids, Cannabinoids, and Chronic Pain: Basis of Potential Utility and Role in Therapy. Cannabis and Cannabinoid Research. PMID 37466474 DOI: 10.1089/can.2023.0064  0.159
2022 Lake S, Assaf RD, Gorbach PM, Cooper ZD. Selective Changes in Medical Cannabis Use Early in the COVID-19 Pandemic: Findings from a Web-Based Sample of Adults in the United States. Cannabis and Cannabinoid Research. PMID 35073161 DOI: 10.1089/can.2021.0115  0.155
2020 Sholler DJ, Huestis MA, Amendolara B, Vandrey R, Cooper ZD. Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids. Pharmacology, Biochemistry, and Behavior. 173059. PMID 33086126 DOI: 10.1016/j.pbb.2020.173059  0.145
2022 Venegas A, Du H, Cooper ZD, Ray LA. Cannabis and alcohol co-use: The effects of intensity of cannabis use among heavy drinkers. Addictive Behaviors. 135: 107443. PMID 35932601 DOI: 10.1016/j.addbeh.2022.107443  0.144
2023 Assaf RD, Javanbakht M, Gorbach PM, Cooper ZD. Cannabis Use and Sharing Practices Among Sexual Minority and Heterosexual Individuals During the COVID-19 Pandemic. Lgbt Health. PMID 37252794 DOI: 10.1089/lgbt.2022.0236  0.139
2023 Brasky TM, Newton AM, Conroy S, Adib A, Adley NC, Strassels SA, Hays JL, Cooper ZD, Wagener TL, Stevens E, Plascak JJ, Krok-Schoen JL. Marijuana and Cannabidiol Use Prevalence and Symptom Management Among Patients with Cancer. Cancer Research Communications. 3: 1917-1926. PMID 37772996 DOI: 10.1158/2767-9764.CRC-23-0233  0.137
2021 Cooper ZD, Abrams DI, Gust S, Salicrup A, Throckmorton DC. Challenges for Clinical Cannabis and Cannabinoid Research in the United States. Journal of the National Cancer Institute. Monographs. 2021: 114-122. PMID 34850896 DOI: 10.1093/jncimonographs/lgab009  0.132
2022 Lake S, Cooper ZD. Understanding Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration in the Era of Legalization. The American Journal of Psychiatry. 179: 702-704. PMID 36181332 DOI: 10.1176/appi.ajp.20220675  0.127
2023 Kapler S, Adery L, Hoftman GD, Amir CM, Grigoryan V, Cooper ZD, Bearden CE. Assessing evidence supporting cannabis harm reduction practices for adolescents at clinical high-risk for psychosis: a review and clinical implementation tool. Psychological Medicine. 1-11. PMID 37882050 DOI: 10.1017/S0033291723002994  0.122
2021 Russo EB, Cuttler C, Cooper ZD, Stueber A, Whiteley VL, Sexton M. Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms. Cannabis and Cannabinoid Research. PMID 34569849 DOI: 10.1089/can.2021.0058  0.118
2023 Lake S, Cooper ZD, Ong K, Lucas P. Shifts in medical cannabis use in Canada during the COVID-19 pandemic. Health Promotion and Chronic Disease Prevention in Canada : Research, Policy and Practice. 43: 119-129. PMID 36924465 DOI: 10.24095/hpcdp.43.3.02  0.117
2021 Siegel R, Sullivan N, Monte AA, Vargas NM, Cooper ZD, Ma Y, Meltzer AC. Motivational interviewing to treat substance use disorders in the emergency department: A scoping review. The American Journal of Emergency Medicine. PMID 33840549 DOI: 10.1016/j.ajem.2021.03.047  0.111
2023 McManus K, Venegas A, Henry B, Cooper ZD, Grodin EN, Ray LA. The role of sex in daily levels of high-risk alcohol and cannabis co-use. Drug and Alcohol Dependence Reports. 9: 100203. PMID 38035048 DOI: 10.1016/j.dadr.2023.100203  0.101
2013 Bedi G, Cooper ZD, Haney M. Medications for Treatment of Marijuana Dependence Interventions For Addiction. 397-406. DOI: 10.1016/B978-0-12-398338-1.00042-7  0.095
2019 Charoensook J, Mert M, Shoemaker E, Cooper Z. 2.10 CANNABIS AND OTHER SUBSTANCE USE, COMORBID PSYCHIATRIC DISORDERS, AND CHILDHOOD ADVERSITY IN AN OUTPATIENT CHILD AND ADOLESCENT PSYCHIATRY CLINIC Journal of the American Academy of Child & Adolescent Psychiatry. 58: S174. DOI: 10.1016/j.jaac.2019.08.102  0.09
2023 Murray CH, Javanbakht M, Cho GD, Gorbach PM, Fulcher JA, Cooper ZD. Changes in Immune-Related Biomarkers and Endocannabinoids as a Function of Frequency of Cannabis Use in People Living With and Without HIV. Cannabis and Cannabinoid Research. PMID 37093248 DOI: 10.1089/can.2022.0287  0.089
2023 Assaf RD, Hamad R, Javanbakht M, Arah OA, Shoptaw SJ, Cooper ZD, Gorbach PM. Associations of U.S. state-level COVID-19 policies intensity with cannabis sharing behaviors in 2020. Research Square. PMID 37577641 DOI: 10.21203/rs.3.rs-3211086/v1  0.087
2023 Meza BPL, Dudovitz RN, Cooper ZD, Tucker JS, Wong MD. Adolescent Cannabis Misuse Scale: Longitudinal Associations with Substance Use, Mental Health, and Social Determinants of Health in Early Adulthood. Substance Use & Misuse. 1-10. PMID 37158563 DOI: 10.1080/10826084.2023.2201852  0.075
2022 Assaf RD, Gorbach PM, Cooper ZD. Changes in medical and non-medical cannabis use among United States adults before and during the COVID-19 pandemic. The American Journal of Drug and Alcohol Abuse. 1-7. PMID 35130464 DOI: 10.1080/00952990.2021.2007257  0.065
2021 Kozak K, H Smith P, Lowe DJE, Weinberger AH, Cooper ZD, Rabin RA, George TP. A systematic review and meta-analysis of sex differences in cannabis use disorder amongst people with comorbid mental illness. The American Journal of Drug and Alcohol Abuse. 1-13. PMID 34280058 DOI: 10.1080/00952990.2021.1946071  0.065
2017 Piomelli D, Cooper Z, Abrams D, Grant I, Patel S. A Guide to the National Academy of Science Report on Cannabis: An Exclusive Discussion with Panel Members. Cannabis and Cannabinoid Research. 2: 155-159. PMID 28861515 DOI: 10.1089/can.2017.29009.dpi  0.015
2017 Cooper ZD. A Guide to the National Academy of Science Report on Cannabis: An Exclusive Discussion with Panel Members Cannabis Cannabinoid Res.. 2: 155-159. DOI: 10.1089/can.2017.29009.dpi  0.015
Hide low-probability matches.